Consensus statement: The evaluation and treatment of people with epilepsy and affective disorders

Epilepsy and Behavior

Volumn 13, Issue SUPPL. 1, 2008, Pages

  Barry, John J ^a   Ettinger, Alan B ^b   Friel, Peggy ^c   Gilliam, Frank G ^d   Harden, Cynthia L ^e   Hermann, Bruce ^f   Kanner, Andres M ^g   Caplan, Rochelle ^h   Plioplys, Sigita ⁱ   Salpekar, Jay ^j   Dunn, David ^k,l   Austin, Joan ^k,l   Jones, Jana ^f  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^c SWEDISH MEDICAL CENTER   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^g RUSH MEDICAL COLLEGE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ CHILDREN'S MEMORIAL HOSPITAL   (United States)

^j GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^k INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l INDIANA UNIVERSITY SCHOOL OF NURSING   (United States)

more..

Author keywords

Antidepressants; Anxiety; Bipolar disorder; Depression; Ictal depression; Interictal depression; Intractable epilepsy; Postictal depression; Suicidality; Temporal lobe epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CITALOPRAM; DULOXETINE; ESCITALOPRAM; ETIRACETAM; FELBAMATE; FLUOXETINE; FLUVOXAMINE MALEATE; GABAPENTIN; LAMOTRIGINE; MONOAMINE OXIDASE INHIBITOR; OXCARBAZEPINE; PAROXETINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; PREGABALIN; PRIMIDONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TIAGABINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; VIGABATRIN; ZONISAMIDE;

AGITATION; AKATHISIA; ANTICHOLINERGIC SYNDROME; ANXIETY; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; BLURRED VISION; CLINICAL ASSESSMENT TOOL; CLINICAL EXAMINATION; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; COMORBIDITY; CONFUSION; CONSENSUS; CONSTIPATION; DEPERSONALIZATION; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIZZINESS; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FATALITY; DRUG HALF LIFE; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG OVERDOSE; DRUG POTENTIATION; DRUG RESPONSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERANCE; DRUG WITHDRAWAL; DYSKINESIA; EJACULATION DISORDER; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAPHY; EPILEPSY; EVIDENCE BASED MEDICINE; FAMILY THERAPY; FATIGUE; FEAR; GASTROINTESTINAL SYMPTOM; HEALTH CARE ACCESS; HEART ARRHYTHMIA; HELP SEEKING BEHAVIOR; HUMAN; HYPERNATREMIA; HYPERTENSION; INSOMNIA; IRRITABILITY; LEARNING DISORDER; LETHARGY; LIBIDO DISORDER; MANIA; MEDICAL EXPERT; MEMORY DISORDER; MENTAL HEALTH; MENTAL HEALTH SERVICE; MENTAL STRESS; MINI MENTAL STATE EXAMINATION; MOOD DISORDER; MORTALITY; MUSCLE RIGIDITY; MYOCLONUS EPILEPSY; NAUSEA; NEUROTOXICITY; NONHUMAN; ORGASM DISORDER; ORTHOSTATIC HYPOTENSION; PARESTHESIA; PATHOPHYSIOLOGY; PATIENT ASSESSMENT; PRACTICE GUIDELINE; PREVALENCE; PSYCHOEDUCATION; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; PSYCHOSIS; PSYCHOTHERAPY; RECOMMENDED DRUG DOSE; REMISSION; RISK ASSESSMENT; RISK FACTOR; SEDATION; SEIZURE; SEROTONIN SYNDROME; SEXUAL AROUSAL DISORDER; SEXUAL DYSFUNCTION; SIDE EFFECT; SOCIAL SUPPORT; SUICIDAL IDEATION; SWEATING; SYMPTOM; TREMOR; URINARY HESITANCY; VAGUS NERVE STIMULATION; VIVID DREAM; WEIGHT GAIN; WITHDRAWAL SYNDROME;

CONSENSUS; EPILEPSY; EVALUATION STUDIES AS TOPIC; HUMANS; MOOD DISORDERS;

EID: 44649127304     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2008.04.005     Document Type: Article

References (357)

1. Evans D.L., and Charney D.S. Mood disorders and medical illness: a major public health problem [editorial]. Biol Psychiatry 54 (2003) 177-180
2. Michaud C.M., Murray C.J., and Bloom B.R. Burden of disease: implications for future research. JAMA 285 (2001) 535-539
3. Katon W.J. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 54 (2003) 216-226
4. Tellez-Zenteno J.F., Patten S.B., Jetté N., Williams J., and Wiebe S. Psychiatric comorbidity in epilepsy: A population-based analysis. Epilepsia 48 12 (2007) 2336-2344
5. Jacoby A., Baker G.A., Steen N., et al. The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study. Epilepsia 37 (1996) 148-161
6. O'Donoghue M.F., Goodridge D.M., Redhead K., et al. Assessing the psychosocial consequences of epilepsy: a community-based study. Br J Gen Pract 49 (1999) 211-214
7. Edeh J., and Toone B. Relationship between interictal psychopathology and the type of epilepsy: results of a survey in general practice. Br J Psychiatry 151 (1987) 95-101
8. Kanner A.M., Kozak A.M., and Frey M. The use of sertraline in patients with epilepsy: is it safe?. Epilepsy Behav 1 (2000) 100-105
9. Wiegartz P., Seidenberg M., Woodard A., et al. Co-morbid psychiatric disorder in chronic epilepsy: recognition and etiology of depression. Neurology 53 Suppl. 2 (1999) S3-S8
10. Ettinger A.B., Weisbrot D.M., Nolan E.E., et al. Symptoms of depression and anxiety in pediatric epilepsy patients. Epilepsia 39 (1998) 595-599
11. Gilliam F.G., Santos J., Vahle V., Carter J., Brown K., and Hecimovic H. Depression in epilepsy: ignoring clinical expression of neuronal network dysfunction?. Epilepsia 45 Suppl. 2 (2004) 28-33
12. Kimiskidis V.K., Triantafyllou N.I., Kararizou E., et al. Depression and anxiety in epilepsy: the association with demographic and seizure-related variables. Ann Gen Psychiatry 6 (2007) 28
13. Ettinger A.B., Reed M., Cramer J., and for the Epilepsy Impact Project Group. Depression and co-morbidity in community-based patients with epilepsy or asthma. Neurology 63 (2004) 1008-1014
14. Gilliam F., and Kanner A.M. The treatment of depression in epilepsy. Epilepsy Behav 3 (2002) 6
15. Jones J.E., Watson R., Sheth J., Caplan R., Koehn M., Seidenberg M., and Hermann B. Psychiatric comorbidity in patients with epilepsy. Dev Med Child Neurol 49 (2007) 493-497
16. Forsgren L., and Nystrom L. An incident case referent study of epileptic seizures in adults. Epilepsy Res 6 (1990) 66-81
17. Hesdorffer D.C., Hauser W.A., Annegers J.F., et al. Major depression is a risk factor for seizures in older adults. Ann Neurol 47 (2000) 246-249
18. Hesdorffer D.C., Hauser W.A., Olafsson E., Ludvigsson P., and Kjartansson O. Depression and suicidal attempt as risk factor for incidental unprovoked seizures. Ann Neurol 59 (2006) 35-41
19. Gilliam F., Kuzniecky R., Faught E., et al. Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia 38 (1997) 233-236
20. Cramer J.A., Blum D., Fanning K., Reed M., and for the Epilepsy Impact Project Group. The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy. Epilepsy Behav 5 (2004) 337-342
21. Cramer J.A., Blum D., Reed M., et al. The influence of comorbid depression on quality of life for people with epilepsy. Epilepsy Behav 4 3 (2003) 515-521
22. Kanner AM, Gilliam FG, Barry J, Hermann B, Meador KJ. Differential impact of mood and anxiety disorders on the quality of life and perception of adverse events to antiepileptic drugs in patients with epilepsy. In: Abstracts from the 2007 Annual Meeting of the American Epilepsy Society. Epilepsia 2007;48(s6).
23. Program 1.283, Abstract Viewer. Philadelphia: American Epilepsy Society; 2007.
24. Hitiris N, Mohanraj R, Norrie J, Sills GJ, Brodie MJ. Predictors of pharmacoresistant epilepsy. Epilepsy Res 2007;75:192-6.
25. Kanner A.M., Byrne R., Smith M.C., Balabanov A., and Frey M. Does a lifetime history of depression predict a worse postsurgical seizure outcome following a temporal lobectomy [abstract]?. Ann Neurol 60 S10 (2006) 19
26. Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition. Text Revised. Washington, DC: American Psychiatric Press; 2000.
27. Barraclough B. Suicide and epilepsy. In: Reynolds E.H., and Trimble M.R. (Eds). Epilepsy and psychiatry (1981), Churchill Livingstone, Edinburgh 72-76
28. Robertson M.M. Suicide, parasuicide, and epilepsy. In: Engel J., and Pedley T.A. (Eds). Epilepsy: a comprehensive textbook (1997), Lippincott-Raven, Philadelphia 2141-2151
29. Rafnsson V., Olafsson E., Hauser W.A., et al. Cause-specific mortality in adults with unprovoked seizures: a population-based incidence cohort study. Neuroepidemiology 20 (2001) 232-236
30. Nilsson L., Tomson T., Farahmand B.Y., et al. Cause-specific mortality in epilepsy: a cohort study of more than 9,000 patients once hospitalized for epilepsy. Epilepsia 38 (1997) 1062-1068
31. Christensen J., Vestergaard M., Mortensen P.B., Sidenius P., and Agerbo E. Epilepsy and risk of suicide: a population-based case-control study. Lancet Neurol 6 (2007) 666-667
32. Kanner A.M., Soto A., and Gross-Kanner H. Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy. Neurology 62 (2004) 708-713
33. Blanchet P., and Frommer G.P. Mood change preceding epileptic seizures. J Nerv Ment Dis 174 (1986) 471-476
34. Daly D. Ictal affect. Am J Psychol 115 (1958) 97-108
35. Kraepelin E. Psychiatrie vol. 3 (1923), Johann Ambrosius Barth, Leipzig
36. Bleuler E. Lehrbuch der Psychiatrie. 8th ed. (1949), Springer, Berlin
37. Gastaut H., Roger J., and Lesèvre N. Différenciation psychologique des épileptiques en fonction des formes électrocliniques de leur maladie. Rev Psychol Appl 3 (1953) 237-249
38. Blumer D., and Altshuler L.L. Affective disorders. In: Engel J., and Pedley T.A. (Eds). Epilepsy: a comprehensive textbook vol. II (1998), Lippincott-Raven, Philadelphia 2083-2099
39. Kanner A.M., Wuu J., Barry J., Hermann B., Meador K.J., and Gilliam F. Atypical depressive episodes in epilepsy: a study of their clinical characteristics and impact on quality of life. Neurology 62 Suppl. 5 (2004) A249
40. Mendez M.F., Cummings J., Benson D., et al. Depression in epilepsy: significance and phenomenology. Arch Neurol 43 (1986) 766-770
41. Collaborative Group for Epidemiology of Epilepsy. Reactions to antiepileptic drugs: a multicenter survey of clinical practice. Epilepsia 1986;27:323-30.
42. McConnell H., and Duncan D. Treatment of psychiatric comorbidity in epilepsy. In: McConnell H., and Snyder P. (Eds). Psychiatric comorbidity in epilepsy (1998), American Psychiatric Press, Washington, DC 245
43. Brent D., Crumrine P., and Varma R. Phenobarbital treatment and major depressive disorder in children with epilepsy. Pediatrics 80 (1987) 909-917
44. Ferrari N., Barabas G., and Matthews W. Psychological and behavioral disturbance among epileptic children treated with barbiturate anticonvulsants. Am J Psychol 140 (1983) 112-113
45. Smith D., and Collins J. Behavioral effects of carbamazepine, phenobarbital, phenytoin and primidone. Epilepsia 28 (1987) 598
46. Barabas G., and Matthews W. Barbiturate anticonvulsants as a cause of severe depression. Pediatrics 82 (1988) 284-285
47. Ring H., and Reynolds E. Vigabatrin and behavior disturbance. Lancet 335 (1990) 970
48. McConnell H., Synder P.J., Duffy J.D., et al. Neuropsychiatric side effects related to treatment with felbamate. J Neuropsychiatry Clin Neurosci 8 3 (1996) 341-346
49. Kanner A.M., Faught E., French J., et al. Psychiatric adverse events caused by topiramate and lamotrigine: a postmarketing prevalence and risk factor study. Epilepsia 41 Suppl. 7 (2000) 169
50. Gilliam F.G., Barry J.J., Meador K.J., Hermann B.P., Vahle V., and Kanner A.M. Rapid detection of major depression in epilepsy: a multicenter study. Lancet Neurol 5 (2006) 399-405
51. Jones J.E., Hermann B.P., Woodard J.L., et al. Screening for major depression in epilepsy with common self-report depression inventories. Epilepsia 46 (2005) 731-735
52. Ettinger A.B., Reed M.L., Goldberg J.F., and Hirschfeld R.M. Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders. Neurology 65 (2005) 535-540
53. Kanner A.M., and Weisbrot D. Psychiatric assessment of the epileptic patient: a non-psychiatrist perspective. In: Ettinger A., and Kanner A.M. (Eds). Psychiatric issues in epilepsy: a practical guide to diagnosis and treatment. 2nd ed. (2007), Lippincott Williams & Wilkins, Philadelphia 119-132
54. Hermann B.P., Trenerry M.R., and Colligan R.C. Learned helplessness, attributional style, and depression in epilepsy. Bozeman Epilepsy Surgery Consortium. Epilepsia 37 (1996) 680-686
55. Quiske A., Helmstaedter C., Lux S., and Elger C.E. Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis. Epilepsy Res 39 (2000) 121-125
56. Mula M., Trimble M.R., and Sander J.W.A.S. The role of hippocampal sclerosis in topiramate-related depression and cognitive deficits in people with epilepsy. Epilepsia 44 (2003) 1573-1577
57. Mula M., Sander J.W., and Trimble M.R. The role of hippocampal sclerosis in antiepileptic drug-related depression in patients with epilepsy: a study on levetiracetam. Seizure 15 (2006) 405-408
58. Briellmann R.S., Hopwood M.J., and Jackson G.D. Major depression in temporal lobe epilepsy with hippocampal sclerosis: clinical and imaging correlates. J Neurol Neurosurg Psychiatry 78 (2007) 1226-1230
59. Richardson E.J., Griffith H.R., Martin R.C., et al. Structural and functional neuroimaging correlates of depression in temporal lobe epilepsy. Epilepsy Behav 10 (2007) 242-249
60. Bromfield EB, Altshuler L, Leiderman DB, et al. Cerebral metabolism and depression in patients with complex partial seizures [published erratum appears in Arch Neurol 1992;49:976]. Arch Neurol 1992;49:617-23.
61. Salzberg M., Taher T., Davie M., et al. Depression in temporal lobe epilepsy surgery patients: an FDG-PET study. Epilepsia 47 (2006) 2125-2130
62. Victoroff J.I., Benson F., Grafton S.T., Engel Jr. J., and Mazziotta J.C. Depression in complex partial seizures. electroencephalography and cerebral metabolic correlates. Arch Neurol 51 (1994) 155-163
63. Gilliam F.G., Santos J., Vahle V., Carter J., Brown K., and Hecimovic H. Depression in epilepsy: ignoring clinical expression of neuronal network dysfunction?. Epilepsia 45 s2 (2004) 28-33
64. Gilliam F.G., Maton B.M., Martin R.C., et al. Hippocampal 1H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy. Neurology 68 (2007) 364-368
65. Giovacchini G., Toczek M.T., Bonwetsch R., et al. 5-HT1A receptors are reduced in temporal lobe epilepsy after partial-volume correction. J Nucl Med 46 (2005) 1128-1135
66. Theodore W.H., Hasler G., Giovacchini G., et al. Reduced hippocampal 5HT1A PET receptor binding and depression in temporal lobe epilepsy. Epilepsia 48 (2007) 1526-1530
67. Hasler G., Bonwetsch R., Giovacchini G., et al. 5-HT1A receptor binding in temporal lobe epilepsy patients with and without major depression. Biol Psychiatry 62 (2007) 1258-1264
68. Savic I., Lindstrom P., Gulyas B., Halldin C., Andree B., and Farde L. Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy. Neurology 62 (2004) 1343-1351
69. Elger C.E., Helmstaedter C., and Kurthen M. Chronic epilepsy and cognition. Lancet Neurol 3 (2004) 663-672
70. Loring D.W., Marino S., and Meador K.J. Neuropsychological and behavioral effects of antiepilepsy drugs. Neuropsychol Rev 17 (2007) 413-425
71. Dulay M.F., Schefft B.K., Fargo J.D., Privitera M.D., and Yeh H. Severity of depressive symptoms, hippocampal sclerosis, auditory memory, and side of seizure focus in temporal lobe epilepsy. Epilepsy Behav 5 (2004) 522-531
72. Helmstaedter C., Sonntag-Dillender M., Hoppe C., and Elger C.E. Depressed mood and memory impairment in temporal lobe epilepsy as a function of focus lateralization and localization. Epilepsy Behav 5 (2004) 696-701
73. Paradiso S., Hermann B.P., Blumer D., Davies K., and Robinson R.G. Impact of depressed mood on neuropsychological status in temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 70 (2001) 180-185
74. Pulliainen V., Kuikka P., and Kalska H. Are negative mood states associated with cognitive function in newly diagnosed patients with epilepsy?. Epilepsia 41 (2000) 421-425
75. Tracy J.I., Lippincott C., Mahmood T., et al. Are depression and cognitive performance related in temporal lobe epilepsy?. Epilepsia 48 (2007) 2327-2335
76. Stoddart S.D., Craddock N.J., and Jones L.A. Differentiation of executive and attention impairments in affective illness. Psychol Med 37 (2007) 1613-1623
77. Burt D.B., Zembar M., and Niederehe G. Depression and memory impairment: a meta-analysis of the association, its pattern, and specificity. Psychol Bull 117 (1995) 285-305
78. Taylor J.V., Clark L., Cannon D.M., Erickson K., Drevets W.C., and Sahakian B.J. Distinct profiles of neurocognitive function in unmedicated unipolar depression and bipolar II depression. Biol Psychiatry 62 (2007) 917-924
79. Jones J.E., Hermann B.P., Barry J.J., Gilliam F., Kanner A.M., and Meador K.J. Clinical assessment of Axis I psychiatric morbidity in chronic epilepsy: a multicenter investigation. J Neuropsychiatry Clin Neurosci 17 (2005) 172-179
80. Johnson E.K., Jones J.E., Seidenberg M., and Hermann B.P. The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy. Epilepsia 45 (2005) 544-550
81. Kanner A.M., and Nieto J. Depressive disorders in epilepsy. Neurology 53 5, Suppl. 2 (1999) S26-S32
82. Corcoran R., and Thompson P. Epilepsy and poor memory: who complains and what do they mean?. Br J Clin Psychol 32 (1993) 199-208
83. Hendriks M.P., Aldenkamp A.P., van der Vlugt H., Alpherts W.C., and Vermeulen J. Memory complaints in medically refractory epilepsy: relationship to epilepsy-related factors. Epilepsy Behav 3 (2002) 165-172
84. Piazzini A., Canevini M.P., Maggiori G., and Canger R. The perception of memory failures in patients with epilepsy. Eur J Neurol 8 (2001) 613-620
85. Vermeulen J., Aldenkamp A.P., and Alpherts W.C. Memory complaints in epilepsy: correlations with cognitive performance and neuroticism. Epilepsy Res 15 (1993) 157-170
86. Collins K.A., Westra H.A., Dozois D.J.A., and Burns D.D. Gaps in accessing treatment for anxiety and depression: challenges for the delivery of care. Clin Psychol Rev 24 (2004) 583-616
87. Mojtabai R., Olfson M., and Mechanic D. Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders. Arch Gen Psychiatry 59 (2002) 77-84
88. Althaus D., Stefanek J., Hasford J., and Hegerl U. [Knowledge and attitude of the general public regarding symptoms, etiology and possible treatments of depressive illnesses]. Nervenarzt 73 (2002) 659-664
89. Sirey J.A., Bruce M.L., Alexopoulos G.S., Perlick D.A., Friedman S.J., and Meyers B.S. Stigma as a barrier to recovery: perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatr Serv 52 (2001) 1615-1620
90. Quinn H., Nikolov B., Jovine L., et al. How do persons with epilepsy react when they are referred for symptoms of depression?. Epilepsia 47 (2006) 12
91. Rush A.J., Trivedi M.H., Ibrahim H.M., et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 54 (2003) 573-583
92. Pisani F., Spina E., and Oteri G. Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice. Epilepsia 40 Suppl. 10 (1999) S48-S56
93. Montgomery S.A. Antidepressants and seizures: emphasis on newer agents and clinical implications. Int J Clin Pract 59 (2005) 1435-1440
94. Rosenstein D.L., Nelson J.C., and Jacobs S.C. Seizures associated with antidepressants: a review. J Clin Psychiatry 54 (1993) 289-299
95. Cuenca P.J., Holt K.R., and Hoefle J.D. Seizure secondary to citalopram overdose. J Emerg Med 26 (2004) 177-181
96. Balit C.R., Lynch C.N., and Isbister G.K. Bupropion poisoning: a case series. Med J Aust 178 (2003) 61-63
97. Mainie I., McGurk C., McClintock G., and Robinson J. Seizures after buproprion overdose. Lancet 357 (2001) 1624
98. Favale E., Rubino V., Mainardi P., Lunardi G., and Albano C. Anticonvulsant effect of fluoxetine in humans. Neurology 45 (1995) 1926-1927
99. Favale E., Audenino D., Cocito L., and Albano C. The anticonvulsant effect of citalopram as an indirect evidence of serotonergic impairment in human epileptogenesis. Seizure 12 (2003) 316-318
100. McConnell H., and Duncan D. Treatment of psychiatric comorbidity in epilepsy. In: McConnell H., and Snyder P. (Eds). Psychiatric comorbidity in epilepsy (1998), American Psychiatric Press, Washington, DC 245-361
101. Naritoku D.K., Terry W.J., and Helfert R.H. Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve. Epilepsy Res 22 (1995) 53-62
102. Yan Q.S., Mishra P.K., Burger R.L., Bettendorf A.F., Jobe P.C., and Dailey J.W. Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats. J Pharmacol Exp Ther 261 (1992) 652-659
103. Yan Q.S., Jobe P.C., and Dailey J.W. Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Eur J Pharmacol 252 (1993) 105-112
104. Nadkarni S., and Devinsky O. Psychotropic effects of antiepileptic drugs. Epilepsy Curr 5 (2005) 176-181
105. Jobe P.C., Mishra P.K., Adams-Curtis L.E., et al. The genetically epilepsy-prone rat (GEPR). Ital J Neurol Sci 16 (1995) 91-99
106. Clough R.W., Peterson B.R., Steenbergen J.L., et al. Neurite extension of developing noradrenergic neurons is impaired in genetically epilepsy-prone rats (GEPR-3s): an in vitro study on locus coeruleus. Epilepsy Res 29 (1998) 135-146
107. Ryu J.R., Jobe P.C., Milbrandt J.C., et al. Morphological deficits in noradrenergic neurons in GEPR-9s stem from abnormalities in both the locus coeruleus and its target tissues. Exp Neurol 156 (1999) 84-91
108. Jobe P.C., Dailey J.W., and Wernicke J.F. A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders. Crit Rev Neurobiol 13 (1999) 317-356
109. Koval G., VanNuis C., and Davis T.D. Seizures associated with amoxapine. Am J Psychiatry 139 (1982) 845
110. Giannini A.J., and Price W.A. Amoxapine-induced seizures: case reports. J Clin Psychiatry 45 (1984) 358-359
111. Cardoni A.A. Clomipramine (1999), Micromedics Electronic Version, Englewood, CO
112. Terao T., Ohmori O., and Shinkai T. A puzzling case of seizures and visual hallucinations during clomipramine treatment with a high dose but causing a low serum concentration. Acta Psychiatr Scand 99 (1999) 388-390 discussion 390-2
113. DeToledo J.C., Haddad H., and Ramsay R.E. Status epilepticus associated with the combination of valproic acid and clomipramine. Ther Drug Monit 19 (1997) 71-73
114. Perroud N., Lazignac C., Baleydier B., Cicotti A., Maris S., and Damsa C. Restless legs syndrome induced by citalopram: a psychiatric emergency?. Gen Hosp Psychiatry 29 (2007) 72-74
115. Ickowicz A. Bupropion-methylphenidate combination and grand mal seizures. Can J Psychiatry 47 (2002) 790-791
116. Pesola G.R., and Avasarala J. Bupropion seizure proportion among new-onset generalized seizures and drug-related seizures presenting to an emergency department. J Emerg Med 22 (2002) 235-239
117. Davidson J. Seizures and bupropion: a review. J Clin Psychiatry 50 (1989) 256-261
118. Hoffman B.F., and Wachsmuth R. Maprotiline and seizures. J Clin Psychiatry 43 (1982) 117-118
119. Ramirez A.L. Seizures associated with maprotiline. Am J Psychiatry 140 (1983) 509-510
120. Molnar G. Seizures associated with high maprotiline serum concentrations. Can J Psychiatry 28 (1983) 555-556
121. Atri P.B., and Julius D.A. Maprotiline hydrochloride associated with a clinical state of catatonic stupor and epileptic encephalogram. J Clin Psychopharmacol 4 (1984) 207-209
122. Bernard P.G., and Levine M.S. Maprotiline-induced seizures. South Med J 79 (1986) 1179-1180
123. Ettinger A.B. Psychotropic effects of antiepileptic drugs. Neurology 67 (2006) 1916-1925
124. Ettinger A.B., Kustra R.P., Hammer A.E., and Messenheimer J.A. Effects of lamotrigine on mood in adult patients with generalized tonic-clonic seizures. Epilepsia 46 Suppl. 8 (2005) 174
125. Harden C.L., Pulver M.C., Ravdin L.D., Blagovest N., Halper J.P., and Labar D.R. A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav 1 (2000) 93-99
126. Pande A.C., Pollack M.H., Crockatt J., et al. Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharmacol 20 (2000) 467-471
127. Pande A.C., Crockatt J.G., Feltner D.E., et al. Pregabalin in generalized anxiety disorder: a placebo-controlled trial. Am J Psychiatry 160 (2003) 533-540
128. Brent D.A., Crumrine P.K., Varma R., Brown R.V., and Allan M.J. Phenobarbital treatment and major depressive disorder in children with epilepsy. Pediatrics 80 (1987) 909-917
129. Kanner A.M., Wuu J., Faught E., Tatum W.O., Fix A., and French J.A. A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events. Epilepsy Behav 4 (2003) 548-552
130. Mula M., Trimble M.R., Lhatoo S.D., and Sander J.W. Topiramate and psychiatric adverse events in patients with epilepsy. Epilepsia 44 (2003) 659-663
131. Dursun S.M., Mathew V.M., and Reveley M.A. Toxic serotonin syndrome after fluoxetine plus carbamazepine. Lancet 342 (1993) 442-443
132. Rosenhagen M.C., Schmidt U., Weber F., and Steiger A. Combination therapy of lamotrigine and escitalopram may cause myoclonus. J Clin Psychopharmacol 26 (2006) 346-347
133. Paul M.A., Gray G.W., Love R.J., and Lange M. SSRI effects on psychomotor performance: assessment of citalopram and escitalopram on normal subjects. Aviat Space Environ Med 78 (2007) 693-697
134. Wilson K., and Mottram P. A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis. Int J Geriatr Psychiatry 19 (2004) 754-762
135. Mendhekar D.N., Gupta D., and Girotra V. Sertraline-induced hypomania: a genuine side-effect. Acta Psychiatr Scand 108 (2003) 70-74
136. Dording C.M., Mischoulon D., Petersen T.J., et al. The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists. Ann Clin Psychiatry 14 (2002) 143-147
137. Bridge J.A., Barbe R.P., Birmaher B., Kolko D.J., and Brent D.A. Emergent suicidality in a clinical psychotherapy trial for adolescent depression. Am J Psychiatry 162 (2005) 2173-2175
138. Morrell M.J., Flynn K.L., Done S., Flaster E., Kalayjian L., and Pack A.M. Sexual dysfunction, sex steroid hormone abnormalities, and depression in women with epilepsy treated with antiepileptic drugs. Epilepsy Behav 6 (2005) 360-365
139. Papakostas G.I. Limitations of contemporary antidepressants: tolerability. J Clin Psychiatry 68 Suppl. 10 (2007) 11-17
140. Schatzberg A.F. Safety and tolerability of antidepressants: weighing the impact on treatment decisions. J Clin Psychiatry 68 Suppl. 8 (2007) 26-34
141. Segraves R.T. Sexual dysfunction associated with antidepressant therapy. Urol Clin North Am 34 (2007) 575-579
142. Sareen J., Jagdeo A., Cox B.J., et al. Perceived barriers to mental health service utilization in the United States, Ontario, and The Netherlands. Psychiatr Serv 58 (2007) 357-364
143. Mechanic D. Removing barriers to care among persons with psychiatric symptoms. Health Aff (Millwood) 21 (2002) 137-147
144. Kanner A.M., and Gidal B.E. The use of psychotropic drugs in epilepsy: a review of pharmacokinetic, pharmacodynamic, and safety issues. In: Ettinger A.B., and Kanner A.M. (Eds). Psychiatric issues in epilepsy: a practical guide to diagnosis and treatment. 2nd ed. (2007), Lippincott Williams & Wilkins, Philadelphia 51-66
145. Brent D., Crumrine P., Varma R., Allan M., and Allman C. Phenobarbital treatment and major depressive disorder in children with epilepsy. Pediatrics 80 (1987) 909-917
146. Buelow J., Austin J., Perkins S., Shen J., Dunn D., and Fastenau P. Behavior and mental health problems in children with epilepsy and low IQ. Dev Med Child Neurol 45 (2003) 683-692
147. Caplan R., Siddarth P., Gurbani S., Hanson R., Sankar R., and Shields W.D. Depression and anxiety disorders in pediatric epilepsy. Epilepsia 46 (2005) 720-730
148. Dunn D., Austin J., and Huster G. Symptoms of depression in adolescents with epilepsy. J Am Acad Child Adolesc Psychiatry 38 (1999) 1132-1138
149. Jones J., Watson R., Sheth R., et al. Psychiatric comorbidity in children with new onset epilepsy. Dev Med Child Neurol 49 (2007) 493-497
150. Oguz A., Kurul S., and Dirik E. Relationship of epilepsy-related factors to anxiety and depression scores in epileptic children. J Child Neurol 17 (2002) 37-40
151. Williams J., Steel C., Sharp G.B., et al. Anxiety in children with epilepsy. Epilepsy Behav 4 (2003) 729-732
152. Martinović Z., and Simonović P.R.D. Preventing depression in adolescents with epilepsy. Epilepsy Behav 9 (2006) 619-624
153. Plioplys S. Depression in children and adolescents with epilepsy. Epilepsy Behav 4 Suppl. 3 (2003) S39-S45
154. Ott D., Siddarth P., Gurbani S., et al. Behavioral disorders in pediatric epilepsy: unmet psychiatric need. Epilepsia 44 (2003) 591-597
155. Kanner A.M., and Dunn D.W. Diagnosis and management of depression and psychosis in children and adolescents with epilepsy. J Child Neurol 19 Suppl. 1 (2004) S65-S72
156. Barzman D.H., McConville B.J., Masterson B., et al. Impulsive aggression with irritability and responsive to divalproex: a pediatric bipolar spectrum disorder phenotype?. J Affect Disord 88 (2005) 279-285
157. Donovan S.J., Nunes E.V., Stewart J.W., et al. "Outer-directed irritability": a distinct mood syndrome in explosive youth with a disruptive behavior disorder?. J Clin Psychiatry 64 (2003) 698-701
158. Wozniak J., Biederman J., Kiely K., et al. Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children. J Am Acad Child Adolesc Psychiatry 34 (1995) 867-876
159. Boylan K., Vaillancourt T., Boyle M., and Szatmari P. Comorbidity of internalizing disorders in children with oppositional defiant disorder. Eur Child Adolesc Psychiatry (2007)
160. Leibenluft E., Blair R.J., Charney D.S., and Pine D.S. Irritability in pediatric mania and other childhood psychopathology. Ann NY Acad Sci 1008 (2003) 201-218
161. Vona P, Siddarth P, Lanphier K, et al. Informing parents about the comorbidities of pediatric epilepsy, accepted for publication.
162. Smith K., Siddarth P., Zima B., et al. Unmet mental health needs in pediatric epilepsy: Insights from providers. Epilepsy Behav 11 (2007) 401-408
163. Wu K, Lieber E, Siddarth P, Smith K, Ankar R. Pediatric epilepsy: parents speak up, accepted for publication.
164. Dunn D., and Austin J. Behavior issues in pediatric epilepsy. Neurology 53 (1999) S96-S100
165. Oostrom K., Schouten A., Kruitwagen C.L., Peters A.C., Jennekens-Schinkel A., and for the Dutch Study Group of Epilepsy in Childhood (DuSECH). Epilepsy-related ambiguity in rating the child behavior checklist and the teacher's report form. Epileptic Disord 3 (2001) 39-45
166. Kanner A.M., and Palac S. Neuropsychiatric complications of epilepsy. Curr Neurol Neurosci Rep 2 (2002) 365-372
167. Thome-Souza S., Kuczynski E., Assumpcao Jr. F., et al. Which factors may play a pivotal role on determining the type of psychiatric disorder in children and adolescents with epilepsy?. Epilepsy Behav 5 (2004) 988-994
168. Caplan R, Siddarth P, Stahl L, et al. Childhood absence epilepsy: risk factors for behavioral, cognitive, and linguistic comorbidities, accepted for publication.
169. Dunn D.W., and Austin J.K. Differential diagnosis and treatment of psychiatric disorders in children and adolescents with epilepsy. Epilepsy Behav 5 Suppl. 3 (2004) S10-S17
170. Brent D., Crumrine P., Varma R., Brown R., and Allan M. Phenobarbital treatment and major depressive disorder in children with epilepsy: a naturalistic follow up. Pediatrics 85 (1990) 1086-1091
171. Williams J., Phillips T., Geiebel M., et al. Factors associated with achievement in children with controlled epilepsy. Epilepsy Behav 2 (2001) 217-233
172. Hammen C. Stress and depression. Annu Rev Clin Psychol 1 (2005) 293-319
173. Austin J., and Caplan R. Behavioral and psychiatric comorbidities in pediatric epilepsy: toward an integrative model. Epilepsia 48 (2007) 1639-1651
174. Rodenburg R., Stams G.J., Meijer A.M., Aldenkamp A.P., and Dekovic M. Psychopathology in children with epilepsy: a meta-analysis. J Pediatr Psychol 30 (2005) 453-468
175. Shore C.P., Austin J.K., Huster G.A., and Dunn D.W. Identifying risk factors for maternal depression in families of adolescents with epilepsy. J Spec Pediatr Nurs 7 (2002) 71-80
176. Caplan R., Gillberg C., Dunn D., and Spence S.J. Child psychiatric disorders. In: Engel J., and Pedley T. (Eds). Epilepsy: a comprehensive textbook (2007), Raven Press, New York 2179-2194
177. Austin J.K., Dunn D.W., Johnson C.S., and Perkins S.M. Behavioral issues involving children and adolescents with epilepsy and the impact of their families: recent research data. Epilepsy Behav 5 Suppl. 3 (2004) S33-S41
178. Austin J.K., Huberty T.J., Huster G.A., and Dunn D.W. Academic achievement in children with epilepsy or asthma. Dev Med Child Neurol 40 (1998) 248-255
179. Fastenau P.S., Shen J., Dunn D.W., Perkins S.M., Hermann B.P., and Austin J.K. Neuropsychological predictors of academic underachievement in pediatric epilepsy: moderating roles of demographic, seizure, and psychosocial variables. Epilepsia 45 (2004) 1261-1272
180. Caplan R., Sagun J., Siddarth P., Gurbani S., Koh S., Gowrinathan R., et al. Social competence in pediatric epilepsy: insights into underlying mechanisms. Epilepsy Behav 6 (2005) 218-228
181. Caplan R., Siddarth P., Bailey C.E., et al. Thought disorder: a developmental disability in pediatric epilepsy. Epilepsy Behav 8 (2006) 726-735
182. Goldston D., Walsh A., Mayfield Arnold E., et al. Reading problems, psychiatric disorders, and functional impairment from mid- to late adolescence. J Am Acad Child Adolesc Psychiatry 46 (2007) 25-32
183. Lepistö T., Soininen M., Ceponiene R., Almqvist F., Näätänen R., and Aronen E.T. Auditory event-related potential indices of increased distractibility in children with major depression. Clin Neurophysiol 115 (2004) 620-627
184. Maughan B., Rowe R., Loeber R., and Stouthamer-Loeber M. Reading problems and depressed mood. J Abnorm Child Psychol 31 (2003) 219-229
185. Toren P., Sadeh M., Wolmer L., et al. Neurocognitive correlates of anxiety disorders in children: a preliminary report. J Anxiety Disord 14 (2000) 239-247
186. Grills A., and Ollendick T. Issues in parent-child agreement: the case of structured diagnostic interviews. Clin Child Fam Psychol Rev 5 (2002) 57-83
187. Myers K., and Winters N. Ten-year review of rating scales: II. Scales for internalizing disorders. J Am Acad Child Adolesc Psychiatry 41 (2002) 634-659
188. Angold A., Costello E., and Worthman C. Puberty and depression: the roles of age, pubertal status and pubertal timing. Psychol Med 28 (1988) 51-61
189. Shaffer D., Fisher P., Lucas C.P., Dulcan M.K., and Schwab-Stone M.E. NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry 39 (2000) 28-38
190. Kaufman J., Birmaher B., Brent D., et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36 (1997) 980-988
191. Gadow K., Sprafkin J., Carlson G.A., et al. A DSM-IV-referenced, adolescent self-report rating scale. J Am Acad Child Adolesc Psychiatry 41 (2002) 671-679
192. Sprafkin J., Gadow K.D., Salisbury H., Schneider J., and Loney J. Further evidence of reliability and validity of the Child Symptom Inventory-4: parent checklist in clinically referred boys. J Clin Child Adolesc Psychol 31 (2002) 513-524
193. Brooks S., and Kutcher S. Diagnosis and measurement of anxiety disorder in adolescents: a review of commonly used instruments. J Child Adolesc Psychopharmacol 13 (2003) 351-400
194. Kovacs M. The Children's Depression Inventory (CDI). Psychopharmacol Bull 21 (1985) 995-998
195. Hesdorffer D.C., Hauser W.A., Olafsson E., Udvigsson P., and Kjartansson O. Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol 59 (2006) 35-41
196. Davies S., Heyman I., and Goodman R. A population survey of mental health problems in children with epilepsy. Dev Med Child Neurol 45 (2003) 292-295
197. Flemming J., and Offord D. Epidemiology of childhood depressive disorders: a critical review. J Am Acad Child Adolesc Psychiatry 29 (1990) 571-580
198. March J., Parker D., Sullivan K., Stallings P., and Conners C. The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity. J Am Acad Child Adolesc Psychiatry 36 (1997) 554-565
199. Achenbach T. Manual for the Child Behavior Checklist and Revised Child Behavior Profile. Burlington: Department of Psychiatry, University of Vermont; 1991.
200. Caplan R, Siddarth P, Bailey C, et al. Depression and anxiety in children with epilepsy. In: Annual Meeting of International League Against Epilepsy; Singapore; 2007.
201. Birmaher B., Arbelaez C., and Brent D. Course and outcome of child and adolescent major depressive disorder. Child Adolesc Psychiatr Clin N Am 11 (2002) 619-637
202. Costello E., Pine D.S., Hammen C., et al. Development and natural history of mood disorders. Biol Psychiatry 52 (2002) 529-542
203. Lewinsohn P., Rohde P., Seeley J.R., and Hops H. Comorbidity of unipolar depression: I. Major depression with dysthymia. J Abnorm Psychol 100 (1991) 205-213
204. American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2007;46:107-25.
205. Austin J., McNelis A.M., Shore C.P., Dunn D.W., and Musick B. A feasibility study of a family seizure management program: 'Be Seizure Smart'. J Neurosci Nurs 34 (2002) 30-37
206. Lewis M., Salas I., de la Sota A., et al. Randomized trial of a program to enhance competencies of children with epilepsy. Epilepsia 31 (1990) 101-109
207. Tieffenberg J., Wood E.I., Alonso A., and Tossutti M.F. A randomized field trial of ACINDES: a child-centered training model for children with chronic illnesses (asthma and epilepsy). J Urban Health 77 (2000) 289-297
208. Snead K., Ackerson J., Bailey K., Schmitt M.M., Madan-Swain A., and Martin R.C. Taking charge of epilepsy: the development of a structured psychoeducational group intervention for adolescents with epilepsy and their parents. Epilepsy Behav 5 (2004) 547-556
209. Austin J., Shafer P., and Deering J. Epilepsy familiarity, knowledge, and perceptions of stigma: report from a survey of adolescents in the general population. Epilepsy Behav 3 (2002) 368-375
210. McLeod J., and Austin J.K. Stigma in the lives of adolescents with epilepsy. Epilepsy Behav 4 (2003) 112-117
211. Bishop M.E.M.B. Teachers' knowledge about epilepsy and attitudes toward students with epilepsy: results of a national survey. Epilepsy Behav 8 (2006) 397-405
212. Oostrom K., Schouten A., Olthof T., Peters A.C., and Jennekens-Schinkel A. Negative emotions in children with newly diagnosed epilepsy. Epilepsia 41 (2000) 326-331
213. Houston E., Cunningham C.C., Metcalfe E., et al. The information needs and understanding of 5-10-year old children with epilepsy, asthma or diabetes. Seizure 9 (2000) 340-344
214. Treatment for Adolescents with Depression Study (TADS) Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial. JAMA 2004;292:807-20.
215. Rodenburg R., Marie Meijer A., Dekovic M., and Aldenkamp A.P. Family predictors of psychopathology in children with epilepsy. Epilepsia 47 (2006) 601-614
216. American Academy of Child and Adolescent Psychiatry. Practice Parameter for psychiatric consultation to schools. J Am Acad Child Adolesc Psychiatry 2005;44:1068-83.
217. Chiu S., and Leonard H. Antidepressants: I Selective serotonin reuptake inhibitors (2003), Oxford Univ. Press, New York p. 274-83
218. Hazell P., O'Connell D., Heathcote D., et al. Tricyclic drugs for depression in children and adolescents. Cochrane Database Syst Rev 2 (2002) CD002317
219. Wagner K., and Ambrosini P.J. Childhood depression: pharmacological therapy/treatment. J Clin Child Psychol 30 (2001) 88-97
220. Hammad T., Laughren T., and Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 63 (2006) 332-339
221. Food and Drug Administration. Relationship between psychotropic drugs and pediatric suicidality: review and evaluation of clinical data. 2007 [cited; Available from: .
222. Bridge J., Iyengar S., Salary C.B., et al. Clinical response and risk for reported suicidal ideation and suicidal attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 297 (2007) 1683-1696
223. Thomé-Souza M., Kuczynski E., and Valente K.D. Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression. Epilepsy Behav 10 (2007) 417-426
224. Delbello M., Kowatch R.A., Adler C.M., et al. A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. J Am Acad Child Adolesc Psychiatry 45 (2006) 305-313
225. Findling R., McNamara N.K., Youngstrom E.A., et al. Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. m. J Am Acad Child Adolesc Psychiatry 44 (2005) 409-417
226. Salpekar J., Conry J.A., Doss W., et al. Clinical experience with anticonvulsant medication in pediatric epilepsy and comorbid bipolar spectrum disorder. Epilepsy Behav 9 (2006) 327-334
227. Gonzalez-Heydrich J., Pandina G.J., Fleisher C.A., et al. No seizure exacerbation from risperidone in youth with comorbid epilepsy and psychiatric disorders: a case series. J Child Adolesc Psychopharmacol 14 (2004) 295-310
228. Holzhausen S., Guerreiro M.M., and Baccin C.E.M.A.M. Use of risperidone in children with epilepsy. Epilepsy Behav 10 (2007) 412-416
229. Suppes T., Dennehy E.B., Hirschfeld R.M., et al. The Texas Implementation of Medication Algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry 66 (2005) 870-886
230. Charney D.S., Berman R.M., and Miller H.L. Treatment of depression. In: Schatzberg A.F., and Nemeroff C.B. (Eds). Textbook of psychopharmacology (1998), American Psychiatric Press, Washington, DC 705-731
231. Kanner A.M., and Balabanov A. Depression and epilepsy: how closely related are they?. Neurology 58 8, Suppl 5 (2002) S27-S39
232. Kanner A.M., and Barry J.J. Is the psychopathology of epilepsy different from that of nonepileptic patients?. Epilepsy Behav 2 (2001) 170-186
233. Kanner A.M. Depression and the risk of neurological disorders. Lancet 366 (2005) 1147-1148
234. Evans D.L., and Charney D. Mood disorders and medical illness: a major public health problem. Biol Psychiatry 3 (2003) 177-180
235. Greden J.F. Unmet need: what justifies the search for a new antidepressant?. J Clin Psychiatry 63 Suppl. 2 (2002) 3-7
236. Nierenberg A.A., Peterson T.J., and Alpert J.E. Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy. J Clin Psychiatry 64 Suppl. 15 (2003) 13-17
237. Kennedy S.H., Lam R.W., Nutt D.J., and Thase M.E. Treating depression effectively (2004), Martin Dunitz, New York
238. Judd L.L., Akiskal H.S., Maser J.D., et al. Major depressive disorder: prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord 50 (1998) 97-108
239. Paykel E.S., Ramana R., Cooper Z., Hayhurst H., Kerr J., and Barkocka A. Residual symptoms after partial remission: an important outcome in depression. Psychol Med 25 (1995) 1171-1180
240. Miller I.W., Keitner G.I., Schatzberg A.F., et al. The treatment of chronic depression: Partt 3: Psychological functioning before and after treatment with sertraline or imipramine. J Clin Psychiatry 59 (1998) 608-619
241. Agras W.S. Behavioral therapy. In: Sadock B.J. (Ed). Comprehensive textbook of psychiatry/VI (1995), Williams & Wilkins, Baltimore 1788-1807
242. Hollon S.D., Jarrett R.B., Nierenberg A.A., Thase M.E., Trivedi M., and Rush A.J. Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment?. J Clin Psychiatry 66 (2005) 455-468
243. Keller M.B., McCullough Jr. J.P., Klein D.N., et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 342 (2000) 1462-1470
244. Fava G.A., Rafanelli C., Grandi S., et al. Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry 155 (1998) 1462-1470
245. Davis G.R., Armstrong Jr. H.E., Donovan D.M., and Temkin N.R. Cognitive-behavioral treatment of depressed affect among epileptics: preliminary findings. J Clin Psychol 40 (1984) 930-935
246. Newsom-Davis I., Goldstein H.L., and Fitzpatrick D. Fear of seizures: an investigation and treatment. Seizure 7 (1998) 101-106
247. Robertson M.M., and Trimble M.R. The treatment of depression in patients with epilepsy: a double-blind trial. J Affect Disord 9 (1985) 127-136
248. Obach R.S., and Dalvie D.K. Metabolism of nomifensine to a dihydroisoquinolinium ion metabolite by human myeloperoxidase, hemoglobin, monoamine oxidase A, and cytochrome P450 enzymes. Drug Metab Dispos 34 (2006) 1310-1316
249. Ojemann L.M., Friel P.N., Trejo W.J., et al. Effect of doxepin on seizure frequency in depressed epileptic patients. Neurology 33 (1982) 646-648
250. Ojemann L.M., Baugh-Bookman C., and Dudley D.L. Effect of psychotropic medications on seizure control in patients with epilepsy. Neurology 37 (1987) 1525-1527
251. Havorka J., and Herman E. Nemcova, Treatment of interictal depression with citalopram in patients with epilepsy. Epilepsy Behav 1 (2000) 444-447
252. Specchio L.M., Iudice A., Specchio N., et al. Citalopram as treatment of depression in patients with epilepsy. Clin Neuropharmacol 27 (2004) 133-136
253. Kuhn K.U., Quednow B.B., Thiel M., Falkai P., Maier W., and Elger C.E. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants. Epilepsy Behav 4 (2003) 674-679
254. Blumer D., and Zielenski J.J. Pharmacologic treatment of psychiatric disorders associated with epilepsy. J Epilepsy 1 (1988) 135-150
255. Blumer D. Antidepressant and double antidepressant treatment for the affective disorder of epilepsy. J Clin Psychiatry 58 (1997) 3-11
256. Barry J., Lembke A., Gisbert P.A., and Gilliam F. Affective disorders in epilepsy. In: Ettinger A.B., and Kanner A.M. (Eds). Psychiatric issues in epilepsy: a practical guide to diagnosis and treatment (2007), Lippincott Williams & Williams, Philadelphia 203-247
257. Jobe P.C. Common pathogenic mechanisms between depression and epilepsy: an experimental perspective. Epilepsy Behav 4 (2003) S14-S24
258. Jobe P.C. Current and future therapeutic opportunities in the comorbidity between the epilepsies and affective disorders. Clin EEG Neurosci 35 (2004) 1-3
259. Kanner A.M. Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Biol Psychiatry 54 (2003) 388-398
260. Gilliam F.G. Diagnosis and treatment of mood disorders in persons with epilepsy. Curr Opin Neurol 18 (2005) 129-133
261. Trivedi M.H., Rush A.J., Crismon M.L., et al. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Arch Gen Psychiatry 61 (2004) 669-680
262. Trivedi M.H. Remission of depression and the Texas Medication Algorithm Project. Manag Care Interface Suppl. B (2003) 9-13
263. Katon W., Von Korff M., Lin E., et al. Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA 273 (1995) 1026-1031
264. Katon W., Von Korff M., Lin E., et al. Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Arch Gen Psychaitry 56 (1999) 1109-1115
265. Katon W., Von Korff M., Lin E., et al. The pathways study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychaitry 61 (2004) 1042-1049
266. Trivedi M.H. Using treatment algorithms to bring patients to remission. J Clin Psychiatry 64 Suppl. 2 (2003) 8-13
267. Trivedi M.H., Fava M., Marangell L.B., Osser D.N., and Shelton R.C. Use of treatment algorithms for depression. Prim Care Companion J Clin Psychiatry 8 (2006) 291-298
268. Trivedi M.H., Rush A.J., Gaynes B.N., et al. Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care. Neuropsychopharmacology 32 (2007) 2479-2489
269. Trivedi M. Use of decision support tools for treatment algorithms. CNS Spectr 12 (2007) 9-16
270. Trivedi M.M. The link between depression and physical symptoms. Prim Care Companion J Clin Psychiatry 6 Suppl. 1 (2004) 12-16
271. Sackeim H., Kupfer D.J., Luther J., et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 163 (2006) 1905-1917
272. Souery D., Papakostas G.I., and Trivedi M. Treatment-resistant depression. J Clin Psychiatry 67 Suppl. 6 (2006) 16-22
273. Nierenberg A.A., and White K. What next? A review of pharmacologic strategies for treatment resistant depression. Psychopharmacol Bull 26 (1990) 429-460
274. Shelton R.C. Treatment options for refractory depression. J Clin Psychiatry 60 Suppl. 4 (1999) 57-61
275. Poirier M., and Boyer P. Venlafaxine and paroxetine in treatment-resistant depression: double-blind, randomized comparison. Br J Psychiatry 175 (1999) 12-16
276. De la Gandara J., Aguera L., Rojo J., et al. Use of antidepressant combinations: which, when and why? Results of a Spanish survey. Acta Psychiatr Scand 428 Suppl. (2005) 32-36
277. Nelson J. Managing treatment-resistant major depression. J Clin Psychiatry 64;2003(Suppl. 1):5-12.
278. Fava M. Daytime sleepiness and insomnia as correlates of depression. J Clin Psychiatry 65 Suppl. 16 (2004) 27-32
279. Erman M. Therapeutic options in the treatment of insomnia. J Clin Psychiatry 66 Suppl. 9 (2005) 18-21
280. Pollack M.H. Comorbid anxiety and depression. J Clin Psychiatry 66 Suppl. 8 (2005) 22-29
281. Westanmo A., Gayken J., and Haight R. Duloxetine: a balanced and selective norepinephrine and serotonin-reuptake inhibitor. Am J Health Syst Phar 62 Suppl. 9 (2005) 18-23
282. Meoni P., Hacket D., and Lader M. Pooled analysis of venlafaxine XR efficacy on somatic and psychic symptoms of anxiety in patients with generalized anxiety disorder. Depress Anxiety 19 (2004) 127-132
283. Souery D., Papakostas G.I., and Trivedi M.H. Treatment-resistant depression. J Clin Psychiatry 67 Suppl. 6 (2006) 16-22
284. McMahon F.J., Buervenich S., Charney D., et al. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet 78 (2006) 804-814
285. Hu X.Z., Rush A.J., Charney D., et al. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression. Arch Gen Psychiatry 64 (2007) 783-792
286. Perlis R.H., Purcell S., Fava M., et al. Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. Arch Gen Psychiatry 64 (2007) 689-697
287. Fava M., Rush A.J., Trivedi M.H., et al. Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin North Am 26 (2003) 457-494
288. Fava M., Tomba E., and Grandi S. The road to recovery from depression: don't drive today with yesterday's map. Psychother Psychosom 76 (2007) 260-265
289. Trivedi M.H., Rush A.J., Wisniewski S.R., et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 163 (2006) 28-40
290. Rush A.J., Trivedi M.H., Wisniewski S.R., et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med 354 (2006) 1231-1242
291. Thase M.E., Friedman E.S., Biggs M.M., et al. Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. Am J Psychiatry 164 (2007) 739-752
292. Nierenberg A.A., Fava M., Trivedi M.H., et al. A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatry 163 (2006) 1519-1530 quiz 1665
293. Fava M., Rush A.J., Wisniewski S.R., et al. A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. Am J Psychiatry 163 (2006) 1161-1172
294. McGrath P.J., Stewart J.W., Fava M., et al. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. Am J Psychiatry 163 (2006) 1531-1541
295. Gilliam F., Barry J.J., Hermann B.P., Meador K.J., Vahle V., and Kanner A.M. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol 5 (2006) 399-405
296. Cassem EH. Depression secondary to medical illness. In: Frances A.J., and Hales R.E. (Eds). Review of psychiatry (1988), American Psychiatric Press, Washington, DC 256-273
297. Hirschfeld R.M.A., Williams J.B.W., Spitzer R.L., et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry 157 (2000) 1873-1875
298. Jones J.E., Hermann B.P., Woodard J.L., et al. Screening for major depression in epilepsy with common self-report depression inventories. Epilepsia 46 (2005) 731-735
299. Beck A., and Steer R. Beck Depression Inventory. In: Force T. (Ed). Handbook of psychiatric measures (2000), American Psychiatric Press, Washington, DC 519-523
300. Gilliam F.G., Fessler A.J., Baker G., Vahle V., Carter J., and Attarian H. Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology 62 (2004) 23-27
301. Fakhoury T.A., Barry J., Miller M.J., Hammer A.E., and Vuong A. Lamotrigine in patients with epilepsy and comorbid depressive symptoms. Epilepsy Behav 10 (2007) 155-162
302. Ettinger A.B., Kustra R.P., and Hammer A.E. Effect of lamotrigine on depressive symptoms in adult patients with epilepsy. Epilepsy Behav 10 (2007) 148-154
303. Hermann B.P., and Whitman S. Neurobiological, psychosocial, and pharmacological factors underlying interictal psychopathology in epilepsy. In: Smith D.B., Treiman D.M., and Trimble M.R. (Eds). Advances in neurology (1991), Raven Press, New York 439-452
304. Hermann B.P., and Wyler A.R. Depression, locus of control, and the effects of epilepsy surgery. Epilepsia 30 (1989) 332-338
305. Hermann B.P., Trenerry M.R., and Colligan R.C. Learned helplessness, attributional style, and depression in epilepsy. Bozeman Epilepsy Surgery Consortium. Epilepsia 37 (1996) 680-686
306. Hermann B.P. Psychopathology in epilepsy and learned helplessness. Med Hypoth 5 (1979) 723-729
307. Thompson P.J., and Upton D. The impact of chronic epilepsy on the family. Seizure 1 (1992) 43-48
308. Boland R.J., and Keller M.B. Treatment of depression. In: Schatzberg A.F., and Nemeroff D.B. (Eds). Textbook of psychopharmacology (1998), American Psychiatric Press, Washington, DC 547-565
309. Schatzberg A.F., Cole J.O., and DeBattista C. Manual of clinical psychopharmacology. 4th ed. (2003), American Psychiatric Press, Washington, DC
310. Abramowicz M. Drugs for psychiatric disorders. Treat Guide Med Lett 4 46 (2006) 35-46
311. Thase M.E., Entsuah A.R., and Rudolph R.L. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 178 (2001) 234-241
312. Silverstone P.H., and Ravindran A. Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. J Clin Psychiatry 60 (1999) 22-28
313. In: Bezchlibnyk-Butler K.Z., Jeffries J.J., and Virani A. (Eds). Clinical handbook of psychotropic drugs (2007), Hogrefe & Huber, Cambridge, MA
314. Blumer D. Psychiatric aspects of intractable epilepsy. Adv Exp Med Biol 497 (2002) 133-147
315. Kupfer D.J. Long-term treatment of depression. J Clin Psychiatry 52 suppl. 5 (1991) 28-34
316. Sharma V. Loss of response to antidepressants and subsequent refractoriness: diagnotic issues in a retrospective case series. J Affect Disord 64 (2001) 99-106
317. Schatzberg A.F., Cole J.O., and DeBattista C. Augmentation strategies for treatment-resistant disorders. Manual of clinical psychopharmacology (2003), American Psychiatric Press, Washington, DC 437-480
318. Figiel G.S., McDonald W.M., McCall W.V., et al. Electroconvulsive therapy. In: Schatzberg A.F., and Nemeroff C.B. (Eds). Textbook of psychopharmacology (1998), American Psychiatric Press, Washington, DC 523-545
319. McConnell H., and Duncan D. Treatment of psychiatric comorbidity in epilepsy. In: McConnell H., and Snyder P.J. (Eds). Psychiatric comorbidity in epilepsy: basic mechanisms, diagnosis, and treatment (1998), American Psychiatric Press, Washington, DC 245-362
320. Regenold W.T., Weintraub D., and Taller A. Electroconvulsive therapy for epilepsy and major depression. Am J Geriatr Psychiatry 6 (1998) 180-183
321. Kaufman K.R., Saucedo C., Schaeffer J., Levesque M., Scannell T., and Glouberman M. Electroconvulsive therapy (ECT) for intractable depression following epilepsy neurosurgery. Seizure 5 (1996) 307-312
322. Fink M., Kellner C.H., and Sacheim H.A. Intractable seizures, status epilepticus, and ECT. J ECT Lett 15 (1999) 282-284
323. Lunde M.E., Lee E.K., and Rasmussen K.G. Electroconvulsive therapy in patients with epilepsy. Epilepsy Behav 9 (2006) 355-359
324. Blackwood D.H., Cull R.E., Freeman C.P., Evans J.L., and Mawdsley C.A. A study of epilepsy following ECT. J Neurol Neurosurg Psychiatry 43 (1980) 1098-1102
325. The practice of electroconvulsive therapy: recommendations for treatment, training and privileging. A Task Force Report of the American Psychiatric Association. Washington, DC: American Psychiatric Press; 2001. p. 31-58.
326. Rutherford B., Sneed J., Marissa M., et al. An open trial of aripiprazole augmentation for SSRI non-remitters with late-life depression. Int J Geriatr Psychiatry 22 (2007) 986-991
327. Barry J., and Huynh N. Psychotropic properties of antiepileptic drugs in patients with developmental disabilities. In: Devinsky O., and Westbrook L.E. (Eds). Epilepsy and developmental disabilities (2002), Butterworth Heinemann, Boston 205-218
328. DeBattista C. Augmentation and combination strategies for depression. J Psychopharmacol 20 (2006) 11-18
329. DeBattista C., Hawkins J., and Buckley T. Gonadal and adrenal steroids in the treatment of major depression. Depression Mind Body 2 (2006) 94-98
330. Wolkowitz O.M., Reus V.I., Keebler A., et al. Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry 156 (1999) 646-649
331. Herzog A.G. Psychoneuroendocrine aspects of temporolimbic epilepsy. Psychosomatics 40 (1999) 95-101
332. Herzog A.G. Psychoneuroendocrine aspects of temporolimbic epilepsy: Part II. Epilepsy and reproductive steroids. Psychosomatics 40 (1999) 102-108
333. Herzog A.G. Psychoneuroendocrine aspects of temporolimbic epilepsy: Part III. Case reports. Psychosomatics 40 (1999) 109-116
334. Thase M.E. Pharmacological strategies for treatment-resistant depression: an update on the state of the evidence. Psychiatr Ann 35 (2005) 970-978
335. Gross M., Nakamura L., Pascual-Leone A., and Fregni F. Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies. Acta Psychiatr Scand 116 (2007) 165-173
336. Mogg A., Pluck P., Eranti S.V., et al. A randomized controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depression. Psychol Med (2007) 1-11
337. Herwig U., Fallgatter A.J., Hoppner J., et al. Antidepressant effects of augmentative transcranial magnetic stimulation. Br J Psychiatry 191 (2007) 441-448
338. Schachter S.C. Vagus nerve stmulation therapy summary: five years after FDA approval. Neurology 59 (2002) S48-S55
339. Rush J.A., George M.S., Sackeim H.A., et al. Vagus nerve stimulation for treatment-resistant depression: a multicenter study. Biol Psychiatry 47 (2000) 276-286
340. Nahas Z., Marangell L.B., Husain M.M., et al. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry 66 (2005) 1097-1104
341. Rush A.J., Marangell L.B., Sackeim H., et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry 58 (2005) 347-354
342. George M.S., Rush A.J., Marangell L.B., et al. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry 58 (2005) 364-373
343. Manji H.K., Drevets W.C., and Charney D.S. The cellular neurobiology of depression. Nat Med 7 (2001) 541-547
344. Barry JJ. Psychiatric uses for anticonvulsants. Merritt-Putnam Lectures. CME monograph. West Hartford, CT: American Epilepsy Society; 1999. p. 89-105.
345. Barry J.J., Lembke A., and Bullock K.D. Current status of the utilization of antiepileptic treatments in mood, anxiety and aggression: drugs and devices. Clin EEG Neurosci 35 (2004) 4-13
346. Shukla S., Godwin C.D., Long L.E., and Miller M.G. Lithium-carbamazepine neurotoxicity and risk factors. Am J Psychiatry 141 (1984) 1604-1606
347. In: Schatzberg A.F., Cole J.O., and DeBattista C. (Eds). Manual of clinical psychopharmacology. 3rd ed. vol. 70 (1997), American Psychiatric Press, Washington, DC
348. Shukla S., Mukherjee S., and Decina P. Lithium in the treatment of bipolar disorders associated with epilepsy: an open study. J Clin Psychopharmacol 8 (1988) 201-204
349. Lyketsos C.G., Stoline A.M., Longstreet P., et al. Mania in temporal lobe epilepsy. Neuropsychiatry Neuropsychol Behav Neurol 6 (1993) 19-25
350. Suppes T., Dennehy E.B., Hirschfield R.M.A., et al. The Texas Implementation of Medication Algorithms: update to the algorithms for treatment of bipolar 1 disorders. J Clin Psychiatry 66 (2005) 870-886
351. Barry J.J., and Huynh N. Psychotropic drug use in patients with epilepsy and developmentl disabilities. In: Devinsky O., and Westbrook L.E. (Eds). Epilepsy and developmental disabilities (2002), Butterworth/Heinemann, Boston 205-218
352. Barry J.J. The recognition and management of mood disorders as a comorbidity of epilepsy. Epilepsia 44 Suppl. 4 (2003) 30-40
353. Leppik I.E., and Birnbaum A.K. Epilepsy in the elderly. In: Wyllie E., Gupta A., and Lachhwani D.K. (Eds). The treatment of epilepsy. 4th ed. (2006), Lippincott Williams & Wilkins, New York 593-621
354. Crystal S., Sambamoorthi U., Walkup J.T., and Akincigil A. Diagnosis and treatment of depression in the elderly medicare population: predictors, disparities, and trends. J Am Geriatr Soc 51 (2003) 1718-1728
355. Jenike M.A. Metabolic changes with aging. In: Jenike M.A. (Ed). Geriatric psychiatry and psychopharmacology: a clinical approach (1989), Year Book Medical, Chicago 25-32
356. Sommer B.R., Fenn H., Pompei P., et al. Safety of antidepressants in the elderly. Expert Opin Drug Saf 2 (2003) 367-383
357. Jacobson S.A., Pies R.W., and Greenblatt D.J. Antidepressants. Handbook of geriatric psychopharmacology (2002), American Psychiatric Press, Washington, DC 101-186